U.S. Infrastructure Stock News

SentinelOne (S) is back in focus after launching its Purple AI Agentic Investigation capability and announcing an upcoming integration with Amazon Bedrock AgentCore, two developments that sharpen its pitch in AI-driven cybersecurity. See our latest analysis for SentinelOne. Despite the recent product launches and the upcoming Amazon Bedrock AgentCore integration, SentinelOne’s share price return tells a mixed story, with a 30 day share price return down 19.7%, a 90 day share price return up...

Pomerantz LLP has launched an investigation into Kemper (KMPR) after the insurer disclosed that regulatory changes increasing minimum liability limits are driving greater attorney involvement in claims and higher loss costs, prompting fresh questions for stockholders. See our latest analysis for Kemper. Kemper's share price has come under pressure in recent months, with a 30 day share price return down 15.75% and a 90 day share price return down 19.49%. This has contributed to a 1 year total...

Bitmine Immersion Technologies (BMNR) is back in focus after heavy cryptocurrency market liquidations, renewed debates over Ethereum funding, and mixed signals about how investors are valuing crypto-linked stocks with high short interest. See our latest analysis for Bitmine Immersion Technologies. At a share price of $16.14, Bitmine Immersion Technologies has a 1 day share price return of 2.8%. The 30 day and 90 day share price returns are down 14.5% and 24.1%, while the 1 year total...

With the Federal Reserve signaling that inflation control still takes priority over rate cuts, investors are again paying close attention to balance sheet strength, cash generation, and dividend support. Higher for longer rates can reward companies that already trade on lower P/E and P/B ratios and do not rely heavily on cheap borrowing to fund growth. This article looks at three stocks from a value focused screener that appear closely tied to the latest Fed commentary on inflation, interest...

If you are wondering whether JPMorgan Chase at around US$325 per share is still offering fair value, the starting point is understanding how its current price lines up against different valuation checks. The stock most recently closed at US$325.22, with returns of 1.4% over 7 days, 6.1% over 30 days, a slight decline of 0.1% year to date, and 20.6% over the last year. This gives useful context before comparing that price to estimates of value. Recent coverage of JPMorgan Chase has focused on...

The interim peace agreement between the U.S. and Iran has reduced conflict risk, and Lockheed Martin (LMT) is feeling the impact, with defense stocks facing a broad reset in expectations for new weapons demand. See our latest analysis for Lockheed Martin. Lockheed Martin’s share price has come under pressure, with a 1-day share price return showing a 4.01% decline and a 90-day share price return showing a 17.09% decline. However, the 1-year total shareholder return of 11.51% and 5-year total...

Vornado Realty Trust (VNO) has drawn investor interest after recent share price moves, with the stock up over the past month and past 3 months while longer term returns remain mixed. See our latest analysis for Vornado Realty Trust. At a share price of $37.81, Vornado Realty Trust has seen strong recent momentum, with a 30 day share price return of 18.23% and a 90 day gain of 45.31%, set against a softer 1 year total shareholder return that declined 4.13% and a much stronger 3 year total...

Kroger (KR) has drawn fresh attention after recent share price weakness, with the stock down about 16% over the past month and about 22% over the past 3 months, despite ongoing profitability. See our latest analysis for Kroger. At the latest share price of $56.61, Kroger’s recent momentum has clearly faded, with the stock recording a 1-day share price return of down 8.43% and a 30-day share price return of down 15.82%. However, the 5-year total shareholder return of 60.61% points to a much...

First Busey (BUSE) drew fresh attention after recent trading left the stock at a last close of $28.23. This prompted investors to reassess its performance and business mix across banking, wealth management, and payments. See our latest analysis for First Busey. First Busey’s recent 4.25% 1 month share price return and 18.12% year to date share price return, alongside a 31.56% 1 year total shareholder return, suggests momentum has been building as investors reassess its risk and income...

Recently, Ardagh Metal Packaging reported past-year revenue growth of 18.61% and a net profit increase of 54.55%, achieving a financial score of 7.74 that ranks 9 out of 22 in the Containers & Packaging industry. Despite this earnings momentum, the company is still assessed as financially weak with only average operating efficiency, underscoring a gap between improving results and overall financial strength. We will now explore how this stronger revenue and profit performance may influence...

AI Infrastructure Stocks sit at the crossroads of two powerful forces: real world capacity building and the long term adoption of artificial intelligence. While inflation trends, central bank policy and energy markets keep shifting, one constant is the heavy demand for data centers, power, cooling and connectivity that makes AI possible. This screener focuses on companies that turn that demand into actual cash flow, not just headlines. In this article you will see 3 of the best stocks from...

Atlantis Casino Resort Spa’s 2025 “Once Is All It Takes” brand campaign has received national honors from the Hermes Creative Awards and Viddy Awards, prompting fresh attention on Monarch Casino & Resort (MCRI) stock. See our latest analysis for Monarch Casino & Resort. The awards attention arrives as Monarch Casino & Resort’s share price trades at $130.66, with a 30-day share price return of 11.86% and a 36.05% year-to-date share price return. The 1-year total shareholder return of 55.71%...

In recent months, Universal Corp has seen institutional ownership rise to 95.24% of shares, alongside higher revenue and a very large jump in net profit, underscoring strong operational efficiency and financial health relative to Food & Tobacco peers. At the same time, the stock’s technical picture has turned bearish despite this robust institutional backing, highlighting an unusual disconnect between trading signals and the company’s improving fundamentals. We’ll now examine how stronger...

Deluxe (DLX) has drawn fresh investor attention after recent share price weakness, with the stock down about 3% over the past month and about 16% over the past 3 months. See our latest analysis for Deluxe. At a share price of $22.94, Deluxe has given investors a 3.38% year to date share price return. The 1 year total shareholder return of 63.73% and 3 year total shareholder return of 70.23% point to earlier momentum that contrasts with the recent 90 day share price decline of 15.88%. If you...

Albemarle (ALB) has drawn fresh attention after recent share price weakness, with the stock down 6% over the past month and 4% over the past 3 months. This has prompted investors to reassess its valuation and business mix. See our latest analysis for Albemarle. Beyond the recent weakness, Albemarle’s 1 day share price return of down 3.73% and 7 day return of down 5.91% sit against a year to date share price gain of 11.41%. The 1 year total shareholder return of about 1.9x contrasts with...

What Hubbell's Recent Performance Tells Investors Hubbell (HUBB) has caught investor attention after a period of steady share price gains, with the stock recently closing at $523.69 and posting double digit total returns over the past year and past 3 months. See our latest analysis for Hubbell. Recent trading has added to Hubbell's positive trend, with a 2.91% 1 day share price return and a 10.25% 30 day share price return, alongside a 33.91% 1 year total shareholder return that points to...

Analyst upgrade puts Kanzhun in focus Bernstein’s upgrade of Kanzhun (NasdaqGS:BZ) following its Q1 2026 results has put the stock back on many investors’ radars, with attention on revenue trends, user metrics, and AI driven matching. See our latest analysis for Kanzhun. The upgrade lands after a mixed stretch for Kanzhun, with the share price up 2.62% over 90 days but down 34.48% year to date and the 1 year total shareholder return declining 22.64%. This suggests recent momentum is tentative...

Generac Holdings (GNRC) is stepping up its manufacturing expansion with a new Belvidere, Illinois facility aimed at increasing packaging capacity for large megawatt generators as institutional ownership and earnings expectations draw fresh attention to the stock. See our latest analysis for Generac Holdings. The recent Belvidere expansion comes as Generac Holdings trades at US$279.15, with a 90-day share price return of 38.30% and a 1-year total shareholder return of 119.22%. These figures...

Analyst commentary has recently highlighted Newmark Group (NMRK) as undervalued relative to peers, pointing to supportive valuation metrics and a favorable earnings outlook that together are drawing fresh attention to the stock. See our latest analysis for Newmark Group. Recent trading has been relatively steady, with Newmark Group's share price at $14.87 and a 90-day share price return of 2.20%. Its 1-year total shareholder return of 34.52% reflects momentum that has built over a longer...

SNAP restrictions on sugary and highly processed foods are putting fresh attention on health and wellness food stocks, as billions in assisted grocery spending are reconsidered. For investors, this kind of policy shift can change which companies benefit from consumer demand tied to assistance programs and which feel pressure on sales of less nutritious products. This article looks at 3 stocks from a Health and Wellness Food Companies screener that appear more aligned with cleaner labels and...

BioLife Solutions (BLFS) is back in focus after Prosper Stars & Stripes added the stock to its portfolio again, pointing to the company’s renewed emphasis on core biopreservation media as well as cell and gene therapy exposure. See our latest analysis for BioLife Solutions. Recent trading reflects that shift in attention, with BioLife Solutions showing a 35.84% 90 day share price return and a 22.71% 1 year total shareholder return, while the current share price sits at $26.04 as investors...

Cytokinetics has entered a new phase as a commercial-stage biotech after securing FDA and European Commission approvals for Myqorzo, its first marketed therapy for symptomatic obstructive hypertrophic cardiomyopathy, and beginning its U.S. launch. An important implication is that Cytokinetics now shifts from being purely development-focused to also managing real-world product uptake, reimbursement, and regional rollouts, which can materially reshape its operating profile and risk mix. With...

Skyworks Solutions (SWKS) is back in focus after quarterly revenue and EPS both beat analyst estimates, with CEO Phil Brace pointing to solid execution and improving momentum across the company’s product portfolio as key drivers. See our latest analysis for Skyworks Solutions. At a share price of $72.45, Skyworks Solutions has seen a 32.96% 90 day share price return and a 12.51% year to date share price return, while the 5 year total shareholder return is down 53.17%. This suggests that...

Argan (AGX) is back on investors’ radar after record first quarter fiscal 2027 results highlighted revenue and earnings growth from energy infrastructure projects, along with a fresh quarterly dividend declaration that underscores ongoing shareholder return plans. See our latest analysis for Argan. The latest quarterly update and dividend news arrive alongside a sharp shift in market sentiment, with Argan’s 90 day share price return of 59.53% and year to date share price return of 126.67%...